English
Abatacept Biosimilar - Research Grade
Abatacept Biosimilar - Research Grade, Host: CHO Cells
Artikelnummer
ICH5185-20MG
Verpackungseinheit
20mg
Hersteller
Ichorbio
Verfügbarkeit:
wird geladen...
Preis wird geladen...
Target: CTLA-4 Fc Fusion Protein.
Specificity: Fusion protein of a Fc fragment (human IgG1 isotype) and the extracellular domain of CTLA-4.
Purification method: This fusion protein was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background: Recombinant protein composed of the extracellular domain of CTLA-4 fused with the Fc region of human immunoglobulin gamma 1 (hIgG1). Abatacept binds to CD80 (B7-1) with more avidity than to CD86 (B7-2).
Concentration: 5mg/ml.
Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity: ≥95% monomer by analytical SEC, >95% by SDS Page.
Endotoxin: <1EU/mg Determined by LAL gel clotting assay.
Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Specificity: Fusion protein of a Fc fragment (human IgG1 isotype) and the extracellular domain of CTLA-4.
Purification method: This fusion protein was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background: Recombinant protein composed of the extracellular domain of CTLA-4 fused with the Fc region of human immunoglobulin gamma 1 (hIgG1). Abatacept binds to CD80 (B7-1) with more avidity than to CD86 (B7-2).
Concentration: 5mg/ml.
Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity: ≥95% monomer by analytical SEC, >95% by SDS Page.
Endotoxin: <1EU/mg Determined by LAL gel clotting assay.
Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Verwandte Artikel
Markieren Sie die Artikel, um Sie dem Warenkorb hinzuzufügen oder
Immer für Sie da
Gernot Ensinger, M.Sc.
Laurent Haze
